Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perineural versus IV dexmedetomidine with adductor canal block in total knee arthroplasty
PACTR202006770945823Recruiting
- Sponsor
- Rabab Mahrous
- Start
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of dexmedetomidine in knee osteoarthritis (OA) and postoperative pain (2 arms), sponsored by Rabab Mahrous. Primary endpoint: Duration of analgesia. Started Sep 2019; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
knee osteoarthritis (OA)postoperative pain
Beyond the preview
Go deeper on PACTR202006770945823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202006770945823.